Business
No Borders, Inc. (Ticker: NBDR) Announces Blockchain Patent Filing With the USPTO
No Borders, Inc. (Ticker: NBDR) Announces Blockchain Patent Filing With the USPTO.
About this update from No Borders, Inc.
[{"type":"text","content":"\n Phoenix, AZ, Feb. 04, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- No Borders, Inc. (OTC:NBDR) today announced that it has successfully filed the first blockchain provisional patent for its CBD LabChain platform. This provisional patent, registered as Application Serial #62969531 with the USPTO on Feb. 3, 2020, now allows the Company’s CBD LabChain platform to operate with “Patent Pending” identifiers and messaging. This marks the very first Patent Pending achievement for the No Borders family of companies and is yet another completed Intellectual Property filing that supports the company mission to impact shareholder value by building a valuable portfolio of IP assets. The Provisional Patent for CBD LabChain was filed with the title: “SYSTEM AND METHOD FOR AUTHENTICATING A CBD LAB TEST RESULT USING BLOCKCHAIN TECHNOLOGY.” No Borders, Inc. CEO Joseph Snyder stated, “It has been a long road to get to this day and I am stoked to share our first patent filing with the world! This filing marks a milestone for our Company and our amazing shareholders. We have consistently stated that No Borders is committed to building and owning a strong IP portfolio and I am proud that we have multiple Trademark approvals, in addition to this initial Patent filing. A giant thank you to both Chris Brown and the No Borders Labs teams as well as Andrew Coldicutt and Keith Alan Miller for the legal work they put in to get our filings prepped and really doing an amazing job on behalf of No Borders, Inc.” No Borders, Inc.’s mission in 2020 is to “Make a lot of money, Help a lot of people and Have a lot of FUN!”™  The Company believes its CBD LabChain platform is a key part of that mission. Statistics show that only about 14 percent of Americans have tried CBD due largely to fears of failing work related drug screens. No Borders Naturals now certifies 100% of its products and their efficacy via the Company’s breakthrough CBD LabChain Certification Platform. With the peace of mind that the CBD LabChain Certification provides consumers, No Borders believes that the Company is strategically positioned to scale as a market leader in the explosive 2020 Hemp CBD market. About No Borders Inc. No Borders, Inc. (OTC:NBDR) is a multifaceted corporation specializ...